sorafenib has been researched along with Bone Marrow Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chu, SH; Civin, C; Collector, M; Heiser, D; Huso, D; Kaplan, I; Li, L; Sharkis, SJ; Small, D | 1 |
1 other study(ies) available for sorafenib and Bone Marrow Neoplasms
Article | Year |
---|---|
FLT3-ITD knockin impairs hematopoietic stem cell quiescence/homeostasis, leading to myeloproliferative neoplasm.
Topics: Animals; Bone Marrow; Bone Marrow Neoplasms; Cell Compartmentation; Cell Cycle; Cell Proliferation; Enzyme Activation; Female; fms-Like Tyrosine Kinase 3; Gene Duplication; Gene Expression Regulation, Neoplastic; Gene Knock-In Techniques; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Homeostasis; Male; Mice; Neoplastic Stem Cells; Niacinamide; Phenotype; Phenylurea Compounds; Promoter Regions, Genetic; RNA, Messenger; Side-Population Cells; Signal Transduction; Small Molecule Libraries; Sorafenib; Tandem Repeat Sequences | 2012 |